Optimization of Fluorescence Assay of Cellular Manganese Status for High Throughput Screening

Journal of Biochemical and Molecular Toxicology

Volumn 27, Issue 1, 2013, Pages 42-49

  Kumar, Kevin K ^a   Aboud, Asad A ^a   Patel, Devin K ^a   Aschner, Michael ^a   Bowman, Aaron B ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Fura 2; High Throughput Screening; Manganese; Neurons; Neurotoxicity; Striatal

Indexed keywords

FURA 2; MANGANESE;

ANIMAL CELL; ARTICLE; CELL DENSITY; CELL LEVEL; CELLULAR FURA 2 MANGANESE EXTRACTION ASSAY; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; GEOMETRY; HIGH THROUGHPUT SCREENING; MOUSE; NONHUMAN; PROCESS OPTIMIZATION; SENSITIVITY ANALYSIS;

ANIMALS; CELL COUNT; CELL LINE; CHEMICAL FRACTIONATION; FLUORESCENCE; FLUORESCENT DYES; FURA-2; HIGH-THROUGHPUT SCREENING ASSAYS; MANGANESE; MICE;

EID: 84872606974     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21457     Document Type: Article

References (13)

1. Aschner M, Guilarte TR, Schneider JS, Zheng W. Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol Appl Pharmacol 2007;221(2):131-147.
2. Rabin O, Hegedus L, Bourre JM, Smith QR. Rapid brain uptake of manganese(II) across the blood-brain barrier. J Neurochem 1993;61(2):509-517.
3. Murphy VA, Wadhwani KC, Smith QR, Rapoport SI. Saturable transport of manganese(II) across the rat blood-brain barrier. J Neurochem 1991;57(3):948-954.
4. Aschner M, Erikson KM, Herrero Hernandez E, Tjalkens R. Manganese and its role in Parkinson's disease: from transport to neuropathology. Neuromolec Med 2009;11(4):252-266.
5. Bowman AB, Kwakye GF, Hernandez EH, Aschner M. Role of manganese in neurodegenerative diseases. J Trace Elem Med Biol 2011;25(4):191-203.
6. Crossgrove J, Zheng W. Manganese toxicity upon overexposure. NMR Biomed 2004;17(8):544-553.
7. Kwakye GF, Li D, Kabobel OA, Bowman AB. Cellular fura-2 manganese extraction assay (CFMEA). Curr Protoc Toxicol 2011;Chapt. 12 (Unit 12.18).
8. Kwakye GF, Li D, Bowman AB. Novel high-throughput assay to assess cellular manganese levels in a striatal cell line model of Huntington's disease confirms a deficit in manganese accumulation. Neurotoxicology 2011;32(5):630-639.
9. Johnston PA, Johnston PA. Cellular platforms for HTS: three case studies. Drug Discovery Today 2002;7(6):353-363.
10. Zhang JH, Chung TD, Oldenburg KR. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 1999;4(2):67-73.
11. Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, Persichetti F, Cattaneo E, MacDonald ME. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet 2000;9(19):2799-2809.
12. Kwakye GF, Li D, Kabobel OA, Bowman AB. Cellular fura-2 manganese extraction assay (CFMEA). Curr Protoc Toxicol 2011;Chapt. 12 (Unit 12-18).
13. Inglese J, Auld DS, Jadhav A, Johnson RL, Simeonov A, Yasgar A, Zheng W, Austin CP. Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. Proc Natl Acad Sci U S A 2006;103(31):11473-11478.